Myrtenal mitigates streptozotocin-induced spatial memory deficit via improving oxido inflammatory, cholinergic and neurotransmitter functions in mice

The occurrence of chronic neurodegenerative disorders is on the rise, but with no effective treatment due to the paucity of information on the pathological mechanism underlying these disorders. Thus, this study investigated the role of oral administration of myrtenal in mitigating memory deficits an...

Full description

Saved in:
Bibliographic Details
Main Authors: Isaac Oluwatobi Akefe (Author), Victoria Aderonke Adegoke (Author), Ibrahim Yusuf Lamidi (Author), Matthew Phillip Ameh (Author), Enokela Shaibu Idoga (Author), Simon Azubuike Ubah (Author), Itopa Etudaye Ajayi (Author)
Format: Book
Published: Elsevier, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_918b69f5f5c9420bae3f045bba7640f3
042 |a dc 
100 1 0 |a Isaac Oluwatobi Akefe  |e author 
700 1 0 |a Victoria Aderonke Adegoke  |e author 
700 1 0 |a Ibrahim Yusuf Lamidi  |e author 
700 1 0 |a Matthew Phillip Ameh  |e author 
700 1 0 |a Enokela Shaibu Idoga  |e author 
700 1 0 |a Simon Azubuike Ubah  |e author 
700 1 0 |a Itopa Etudaye Ajayi  |e author 
245 0 0 |a Myrtenal mitigates streptozotocin-induced spatial memory deficit via improving oxido inflammatory, cholinergic and neurotransmitter functions in mice 
260 |b Elsevier,   |c 2022-01-01T00:00:00Z. 
500 |a 2590-2571 
500 |a 10.1016/j.crphar.2022.100106 
520 |a The occurrence of chronic neurodegenerative disorders is on the rise, but with no effective treatment due to the paucity of information on the pathological mechanism underlying these disorders. Thus, this study investigated the role of oral administration of myrtenal in mitigating memory deficits and neuro-biochemical alterations in streptozotocin-demented mice model. Mice (n ​= ​35) were randomly allocated into five cohorts consisting of 7 mice each; Group I: Control mice received vehicle alone; Group II: streptozotocin; Group III: streptozotocin + 100 ​mg/kg myrtenal; Group IV: streptozotocin +200 ​mg/kg myrtenal; and Group V: streptozotocin ​+ ​donepezil 0.5 ​mg/kg. Data from this study demonstrated that the administration of streptozotocin (STZ) impaired spatial memory and induced alterations in markers of oxido-inflammatory response, cholinergic function, cytoarchitecture, and neurotransmitter levels in mice hippocampus. Notably, administration of myrtenal enhanced spatial memory performance in STZ-demented mice by improving the activities of endogenous antioxidant enzymes to protect the brain from oxido-inflammatory stress. Treatment with myrtenal also restored cholinergic function and stabilized the homeostasis of neurotransmitters in STZ-demented mice. The authors infer that fruits rich in myrtenal may be beneficial for treating patients living with dementia associated with Alzheimer's disease. 
546 |a EN 
690 |a Myrtenal 
690 |a Memory 
690 |a Antioxidant 
690 |a Streptozotocin 
690 |a Dementia 
690 |a Mice 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Current Research in Pharmacology and Drug Discovery, Vol 3, Iss , Pp 100106- (2022) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2590257122000268 
787 0 |n https://doaj.org/toc/2590-2571 
856 4 1 |u https://doaj.org/article/918b69f5f5c9420bae3f045bba7640f3  |z Connect to this object online.